About Teresa Berkery

This author has not yet filled in any details.
So far Teresa Berkery has created 2 blog entries.

Launch of In4Kids Clinical Trial Network

By |2023-06-29T14:51:53+01:00February 7th, 2023|

A new network putting children at the centre of decision-making in healthcare was launched today at University College Cork.

Funded by the Health Research Board (HRB), In4Kids, the Irish Network for Children’s Clinical Trials, will support innovative clinical research and trial design for children in Ireland. It is the first clinical trials network in Ireland to focus on children’s health.

Better patient outcomes

Evidence shows that research-active hospitals have better patient care outcomes. In4kids will allow healthcare staff and researchers throughout Ireland to work together through a multidisciplinary network, with access and support for participation in national and international clinical trials with particular emphasis on rare paediatric diseases and high medical need areas.

The network is developing educational and training resources for everyone involved in clinical trials and will soon establish a young persons’ advisory group. The network also aims to ensure that children and their families are involved in clinical research from an early stage and that the research is relevant and accessible to them.

In4kids is the Irish hub in the c4c network, a pioneering European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population.

Children are not little adults

Paediatric patients have developmental, physiological and psychological differences from adults. Medicines and treatments made for adults therefore cannot simply be applied to children.

Professor Geraldine Boylan, lead for the In4kids network and INFANT Centre Director, UCC, said: “All children must have access to innovative therapies and medicines that have been developed with the same rigour and urgency as those developed for adults. We have a great team of investigators in our network and in4kids will support them to roll out the latest clinical trials for children across Ireland.”

Professor Helen Whelton, Head of College of Medicine and Health, UCC said: “In4kids is working to ensure Ireland produces excellent clinical research and clinical trials to benefit all children. We are launching a paediatric network to ensure that every child is seen and heard and has access to the best possible therapies and interventions. Our children deserve and must have the same access to high quality, evidence-based health care as adults.”

Patient representative, Cameron Keighron, who has been living with Type 1 diabetes for 8 years, said: “I am passionate about including the lived experience of people in all elements of research, particularly the voice of young people. Including young people in research is often overlooked but I truly believe that we have an important voice to contribute to shaping a better world, without us, research will never have the full picture.”

As part of the launch, leading experts addressed the challenges and opportunities for clinical trials in children in Ireland as well as announcing a new collaboration between the Glucksman and In4Kids.

Learn more about In4Kids here.

Musgrave partners with UCC to support allergen education and research

By |2022-09-02T14:27:44+01:00September 2nd, 2022|

PRESS RELEASE

Musgrave, Ireland’s leading food retailer, wholesaler and foodservice company, has collaborated with University College Cork (UCC) to advance allergy education and research.

  • New funding will provide grants to students on the new Allergy and Clinical Immunology Postgraduate Programme at UCC
  • Sponsorship will also fund essential studies into anaphylaxis management

In keeping with the Musgrave’s long-standing history of innovation and commitment to supporting communities, this partnership will advance critical research from UCC’s INFANT Centre into anaphylaxis management, which is the management of a severe, potentially life-threatening allergic reactions, in care settings. It will also support the launch of a new online postgraduate programme in Allergy and Clinical Immunology within the Department of Paediatrics and Child Health, UCC.

Ray Bowe, Head of Food Safety and Quality at Musgrave, said: “At Musgrave, we feed one in three people across Ireland every day. We ensure that the food we supply is of the highest quality and safe for those who enjoy it, and this means the continuous management of allergens is a key cornerstone across our supply chains to the end consumer. Food allergens are a significant health risk to vulnerable consumers, with the rate of allergen sufferers increasing in the developed world over the past 30 years. As a result, we were happy to have the opportunity to support this allergy education and research at UCC and CUH. We are keen to see these advancements in how allergies are managed and treated going forward.”

The new Allergy and Clinical Immunology programme at UCC is the first in Ireland that can be undertaken fully online. Aimed at healthcare professionals across a range of disciplines, this programme will provide the essential training needed to prevent, diagnose, and treat allergic and immunological diseases such as asthma, hay fever and food allergies. The support of Musgrave will see a number of grants made available for students on this programme.

Speaking about the partnership, Professor Geraldine Boylan, Professor of Neonatal Physiology and   Director of the INFANT Research Centre said: “The College of Medicine and Health and the INFANT Research Centre at University College Cork is very grateful for the support our research received from industry through corporate philanthropy from Musgrave. This partnership enables us to bring together academic and clinical researchers to address knowledge gaps.  Improved treatment outcomes via translational research for patients will be the rewards for this effort.”

In addition to the programme, Musgrave has also committed to supporting essential research into anaphylaxis management. Speaking about the importance of this research, Dr Juan Trujillo, lead investigator at the INFANT Research Centre and Paediatric Allergist at Cork University Hospital said: “We are investigating how allergies are managed by caregivers and how adrenaline auto-injectors, like the EpiPen, are being used in care settings. Our researchers are driving the change in allergy treatments.”

Go to Top